Petition · Department of Health and Social Care
Fund NHS access to Omaveloxolone for patients with Friedreich's Ataxia
Open for signatures
6,310 signatures
What the petition asks
We call on the Government to fund NHS access to Omaveloxolone in the UK. We believe the drug should also be considered under the HST programme, which we feel is the only appraisal route which reflects the realities of Friedreich's Ataxia. This is a degenerative disease & time is of the essence.
Friedreich's Ataxia patients need access to the drug Omaveloxolone, the only drug available for this disease. Without treatment, this degenerative disease can get worse. Patients & families may have to see their loved ones deteriorate when they are aware there is a drug available to stop the progression of this disease & in many cases, to improve the symptoms. The drug is available in EU countries & America. It passed the safety test in April 2025 and we believe it should be available on the NHS!
Timeline
| 24 Mar 2026 | Petition opened for signatures |
Key facts
Signatures
6,310
Status
Open for signatures
Department
Department of Health and Social Care
Opened
24 Mar 2026
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 26 Jul 2026.